Published in Acta Cardiol on June 01, 2014
What are the differences in presentation of candidates for percutaneous mitral commissurotomy across the world and do they influence the results of the procedure? Arch Cardiovasc Dis (2008) 1.54
Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: insights from RealiseAF. Europace (2013) 1.41
Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry. Circ Arrhythm Electrophysiol (2012) 1.26
Eighteen-year experience with echinococcosus of the heart: clinical and echocardiographic features in 14 patients. Int J Cardiol (2003) 1.19
Intracardiac thrombus in Behçet's disease: two case reports. Thromb J (2005) 1.04
Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes. Int J Hematol (2010) 0.89
Balloon mitral commissurotomy for patients with mitral stenosis in atrial fibrillation: ten-year clinical and echocardiographic actuarial results. J Heart Valve Dis (2005) 0.88
Screening for aspirin resistance in stable coronary artery patients by three different tests. Thromb Res (2007) 0.81
Accuracy of two scores in the diagnosis of stroke subtype in a multicenter cohort study. Ann Emerg Med (2008) 0.80
Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the outcome of coronary artery disease. Coron Artery Dis (2011) 0.79
[Correlation of clinical and angiographic morphology in unstable angina]. Tunis Med (2004) 0.78
The GPIIIa PlA polymorphism and the platelet hyperactivity in Tunisian patients with stable coronary artery disease treated with aspirin. Thromb Res (2010) 0.78
Acute pericardial effusion following atrial fibrillation ablation: characteristics and relationship with arrhythmia recurrences. Arch Cardiovasc Dis (2011) 0.77
Plasma metalloproteinase-12 and tissue inhibitor of metalloproteinase-1 levels and presence, severity, and outcome of coronary artery disease. Am J Cardiol (2007) 0.77
Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease. J Thromb Thrombolysis (2010) 0.77
Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease. Blood Coagul Fibrinolysis (2010) 0.77
Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease. Thromb Res (2008) 0.77
The cyclooxygenase-1 C50T polymorphism is not associated with aspirin responsiveness status in stable coronary artery disease in Tunisian patients. Genet Test Mol Biomarkers (2011) 0.75
Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia. Diagn Pathol (2013) 0.75
[Evaluation of electrocardiogram's interpretation in the emergency department]. Tunis Med (2004) 0.75
[Mobile right atrial thrombus complicated by severe pulmonary embolism treated with low molecular weight heparin]. Tunis Med (2003) 0.75
[A comparison of the effect of oral captopril and nicardipine in hypertensive crisis]. Tunis Med (2008) 0.75
[Closure of ventricular septal defects in an infant]. Tunis Med (2008) 0.75
[Abnormalities of the interatrial septum associated with cerebral ischemia in young adults: contribution of trans-oesophageal echocardiography]. Tunis Med (2008) 0.75
[Cardiac amyloidosis revealing multiple myeloma]. Tunis Med (2005) 0.75
Sustainable Development Goals and the future of cardiovascular health. A statement from the Global Cardiovascular Disease Taskforce. Eur Heart J (2014) 0.75